Dow's Merck Beats Out Rival Bristol In Melanoma Study [Investor's Business Daily]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Investors Business Daily
Technology Related news 4:25 PM ET Track the latest trends and leading stocks in the biotech and pharmaceutical industries. Dow Jones Industrial Average And Dow Stocks: News And Analysis Bristol Drug Shows Promise In Treatment Of Cervical Cancer This Dow Jones Stock Sees Strong Growth In Cancer Drug; Is It Near A Breakout? Gilead's HIV Combo Passes Muster, But Can It Stand Up To Glaxo, Merck? How Two Biotechs Fell On Cancer Partnerships With Bristol-Myers Stocks Make Beefy Gains; Netflix Gaps Up; Ulta Spikes After Close Bristol-Incyte Match Beats Dow's Merck In Combination Trials Biotech Breakout Ahead? Incyte Rising On Success With Merk, Bristol-Myers Dow component Merck ( MRK ) said Friday that its Keytruda outperformed an immuno-oncological counterpart from Bristol-Myers Squibb ( BMY ) in a three-year study of patients with advanced melanoma. But that wasn't enough to move Merck's stock much. On the stock market today , shares of t
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb (NYSE: BMY) had its price target raised by analysts at Wells Fargo & Company from $51.00 to $52.00. They now have an "equal weight" rating on the stock.MarketBeat
- Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb: Market Pessimism Won't Last Forever [Seeking Alpha]Seeking Alpha
- 2 High-Yield Dividend Stocks to Buy and Hold for 10 Years [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/2/24 - Beat
BMY
Sec Filings
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- BMY's page on the SEC website